MSB 0.43% $1.16 mesoblast limited

Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE, page-80

  1. 7,906 Posts.
    lightbulb Created with Sketch. 626
    1. Yes
    2. Yes
    3. Yes
    4. Yes
    5. Yes

    Your question about the potency assay
    A. Yes
    Otherwise all the answers would have to be No if there is no suitable assay
    Last edited by stocksa: 19/07/22
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.16
Change
0.005(0.43%)
Mkt cap ! $1.318B
Open High Low Value Volume
$1.15 $1.17 $1.13 $3.743M 3.261M

Buyers (Bids)

No. Vol. Price($)
4 78561 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 114667 4
View Market Depth
Last trade - 16.10pm 22/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.